论文信息 - Randomized phase II trial of first-line treatment with tailored irinotecan plus S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301) Running head: Tailored IRIS vs. S-1 as first-line therapy for gastric cancer - 字舞流文

Randomized phase II trial of first-line treatment with tailored irinotecan plus S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301) Running head: Tailored IRIS vs. S-1 as first-line therapy for gastric cancer

Y. Tajima | J. Sakamoto | S. Tatebe | S. Saji | M. Kitajima | Y. Sakata | Masahiro Takahashi | Y. Komatsu | Y. Kimura | Yutaka Takahashi | S. Tamura | H. Oda | T. Wakasugi | J. Sakurai